Drug recall · October 31, 2018
Paliperidone Extended Release Tablets 9 mg recall
Why: Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Paliperidone Extended Release Tablets 9 mg, packaged in a) 30-count bottle(NDC 0591-3695-30) , b) 90-count bottle (NDC 0591-3695-19), Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054
- Lots / codes
Lot #: a) 1291192A, Exp 01/2020; b) 1291193A, Exp 01/2020
- Quantity
- 3,785 bottles
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Product was distributed throughout the United States. Bulk product was distributed to Takeda, Deerfield, IL and may have been further distributed.
- Initiated
- August 6, 2018 · Voluntary: Firm initiated
- Classified
- October 25, 2018
- Reported
- October 31, 2018
- Ended
- February 13, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Paliperidone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.